相关实验视频
Updated: Sep 15, 2025

10:31
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
12.5K
贝类过敏治疗的进步:从目前的方法到未来的策略
Sahel Heidari1,2, Thimo Ruethers3,4, Shaymaviswanathan Karnaneedi3,5
1Molecular Allergy Research Laboratory, Australian Institute of Tropical Health and Medicine, James Cook University, Townsville, QLD, Australia. Sahel.heidari@my.jcu.edu.au.
Clinical reviews in allergy & immunology
|July 16, 2025
概括
贝类过敏影响全球1-3%,诊断是具有挑战性的. 超越避免的新疗法,如针对热胺素的免疫疗法,为长期管理提供了希望.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏学 过敏学
- 食品科学 食品科学 食品科学
背景情况:
- 贝类过敏是一种严重的,持续的食物过敏,在全球范围内影响1-3%,由于物种多样性和有限的工具,造成诊断挑战.
- 它是"九大"中的一个主要过敏原,对90%以上的食物过敏病例负责.
- 目前的管理依赖于严格的避免和上腺素,这往往是不够的.
研究的目的:
- 审查针对贝类过敏的向治疗的最新进展.
- 探索超越传统避免策略的新方法,用于长期患者管理.
- 突出托罗普米奥辛作为免疫治疗中的关键过敏原的作用.
主要方法:
- 审查关于贝类过敏诊断和管理的当前文献.
- 对新兴免疫疗法策略的分析,包括过敏原特异性免疫疗法,低过敏性变体,DNA疫苗,免疫调节性和益生菌.
- 讨论正在进行的临床试验和研究疗法.
主要成果:
- 热胺被确定为主要的泛过敏原和免疫治疗的主要标.
- 进展包括过敏原特异性免疫疗法,低过敏性过敏原变体,基于DNA的疫苗,以及新/益生菌方法.
- 几种有前途的疗法正在积极的临床试验中,这表明在有效治疗方面取得了进展.
结论:
- 迫切需要有效的,以患者为中心的治疗方法来治疗贝类过敏.
- 新兴的免疫疗法针对特罗普米奥辛等关键过敏原显示出对脱敏和减轻症状的承诺.
- 研究性疗法为长期管理提供了潜力,改善了患者的生活质量.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
471
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
471
Cross-reactivity
31.5K
Overview
31.5K
Allergic Drug Reactions
981
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
981
Allergic Reactions
28.8K
Overview
28.8K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Desensitization and Tachyphylaxis
2.2K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.2K

